Algert Global’s LifePoint Health, Inc. LPNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-9,718
Closed -$576K 449
2016
Q3
$576K Sell
9,718
-2,367
-20% -$142K 0.17% 221
2016
Q2
$790K Sell
12,085
-1,793
-13% -$122K 0.32% 116
2016
Q1
$961K Sell
13,878
-7,662
-36% -$511K 0.36% 95
2015
Q4
$1.58M Buy
21,540
+420
+2% +$29.9K 0.74% 20
2015
Q3
$1.5M Buy
21,120
+7,960
+60% +$646K 0.83% 15
2015
Q2
$1.14M Buy
13,160
+2,240
+21% +$169K 0.63% 36
2015
Q1
$802K Buy
10,920
+6,550
+150% +$465K 0.45% 70
2014
Q4
$314K Sell
4,370
-460
-10% -$31.9K 0.19% 194
2014
Q3
$334K Buy
+4,830
New +$340K 0.25% 165

Other funds holding LPNT

Algert Global's LPNT Position: Q4 2016 in Review

Algert Global sold out of LifePoint Health, Inc. (LPNT) in Q4 2016, closing a stake of 9,718 shares — an estimated $576K sold.

Algert Global first reported a position in LPNT in Q3 2014 and held it in 9 quarters. The position peaked at $1.58M in Q4 2015. 236 funds tracked by Wall St. Rank hold LPNT as of Q4 2016.

  • Algert Global reported no remaining LifePoint Health, Inc. position as of Q4 2016 after selling out during the quarter.
  • Algert Global sold 9,718 LifePoint Health, Inc. shares in Q4 2016, an estimated $576K.
  • Algert Global first reported a position in LifePoint Health, Inc. in Q3 2014 and held it in 9 quarters.
  • Algert Global's LifePoint Health, Inc. position peaked at $1.58M in Q4 2015.
  • 236 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2016.

Based on Algert Global's 13F filing for Q4 2016, filed 26 Jan 2017.